期刊论文详细信息
BMC Endocrine Disorders
Impact of medical and psychiatric multi-morbidity on mortality in diabetes: emerging evidence
Leonard E Egede1  Kelly J Hunt2  Yumin Zhao1  Mulugeta Gebregziabher2  Cheryl P Lynch1 
[1] Department of General Internal Medicine & Geriatrics, Center for Health Disparities Research, Medical University of South Carolina, 135 Rutledge Avenue, MSC 593, Charleston, SC, USA;Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA
关键词: Veterans;    Elderly;    Mortality;    Comorbidity;    Diabetes;   
Others  :  1085091
DOI  :  10.1186/1472-6823-14-68
 received in 2014-03-21, accepted in 2014-08-04,  发布年份 2014
PDF
【 摘 要 】

Background

Multi-morbidity, or the presence of multiple chronic diseases, is a major problem in clinical care and is associated with worse outcomes. Additionally, the presence of mental health conditions, such as depression, anxiety, etc., has further negative impact on clinical outcomes. However, most health systems are generally configured for management of individual diseases instead of multi-morbidity. The study examined the prevalence and differential impact of medical and psychiatric multi-morbidity on risk of death in adults with diabetes.

Methods

A national cohort of 625,903 veterans with type 2 diabetes was created by linking multiple patient and administrative files from 2002 through 2006. The main outcome was time to death. Primary independent variables were numbers of medical and psychiatric comorbidities over the study period. Covariates included age, gender, race/ethnicity, marital status, area of residence, service connection, and geographic region. Cox regression was used to model the association between time to death and multi-morbidity adjusting for relevant covariates.

Results

Hypertension (78%) and depression (13%) were the most prevalent medical and psychiatric comorbidities, respectively; 23% had 3+ medical comorbidities, 3% had 2+ psychiatric comorbidities and 22% died. Among medical comorbidities, mortality risk was highest in those with congestive heart failure (hazard ratio, HR = 1.92; 95% CI 1.89-1.95), Lung disease (HR = 1.42; 95% CI 1.40-1.44) and cerebrovascular disease (HR = 1.39; 95% CI 1.37-1.40). Among psychiatric comorbidities, mortality risk was highest in those with substance abuse (HR = 1.50; 95% CI 1.46-1.54), psychoses (HR = 1.16; 95% CI 1.14-1.19) and depression (HR = 1.05; 95% CI 1.03-1.07). There was an interaction between medical and psychiatric comorbidity (p = 0.003) so stratified analyses were performed. HRs for effect of 3+ medical comorbidity (2.63, 2.66, 2.15) remained high across levels of psychiatric comorbidities (0, 1, 2+), respectively. HRs for effect of 2+ psychiatric comorbidity (1.69, 1.63, 1.42, 1.38) declined across levels of medical comorbidity (0, 1, 2, 3+), respectively.

Conclusions

Medical and psychiatric multi-morbidity are significant predictors of mortality among older adults (veterans) with type 2 diabetes with a graded response as multimorbidity increases.

【 授权许可】

   
2014 Lynch et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150113170610339.pdf 553KB PDF download
Figure 2. 83KB Image download
Figure 1. 128KB Image download
【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】
  • [1]Bayliss EA, Bayliss MS, Ware JE Jr, Steiner JF: Predicting declines in physical function in persons with multiple chronic medical conditions: what we can learn from the medical problem list. Health Qual Life Outcomes 2004, 2:47. PMID: 15353000
  • [2]Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D: Multi-morbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes 2004, 2:51. PMID: 15380021
  • [3]Findley P, Shen C, Sambamoorthi U: Multi-morbidity and persistent depression among veterans with diabetes, heart disease, and hypertension. Health Soc Work 2011, 36(2):109-119. PMID: 21661300
  • [4]Vyas A, Pan X, Sambamoorthi U: Chronic Condition Clusters and Polypharmacy among Adults. Int J Fam Med 2012, 2012:193168. PMID: 22900173
  • [5]Townsend A, Hunt K, Wyke S: Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use. BMJ 2003, 327(7419):837. PMID: 14551097
  • [6]Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B, Fratiglioni L: Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev 2011, 10(4):430-439. PMID: 21402176
  • [7]Smith SM, Soubhi H, Fortin M, Hudon C, O’Dowd T: Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ 2012, 345:e5205. PMID: 22945950
  • [8]Fortin M, Bravo G, Hudon C, Lapointe L, Dubois MF, Almirall J: Psychological distress and multi-morbidity in primary care. Ann Fam Med 2006, 4(5):417-422. PMID: 17003141.
  • [9]Freund T, Kunz CU, Ose D, Szecsenyi J, Peters-Klimm F: Patterns of multi-morbidity in primary care patients at high risk of future hospitalization. Popul Health Manag 2012, 15(2):119-124. PMID: 22313440
  • [10]Prisciandaro JJ, Gebregziabher M, Grubaugh AL, Gilbert GE, Echols C, Egede LE: Impact of psychiatric comorbidity on mortality in veterans with type 2 diabetes. Diabetes Technol Ther 2011, 13(1):73-78. PMID: 21175275
  • [11]Steinman MA, Lee SJ, John Boscardin W, Miao Y, Fung KZ, Moore KL, Schwartz JB: Patterns of multi-morbidity in elderly veterans. J Am Geriatr Soc 2012, 60(10):1872-1880. PMID: 23035702
  • [12]Miller DR, Safford MM, Pogach LM: Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 2004, 27(Suppl 2):B10-B21. PMID: 15113777
  • [13]Egede LE, Lynch CP, Gebregziabher M, Hunt KJ, Echols C, Gilbert GE, Mauldin PD: Differential Impact of Longitudinal Medication Non-Adherence on Mortality by Race/Ethnicity among Veterans with Diabetes. J Gen Intern Med 2013, 28(2):208-15. Sep 5 PMID: 22948932
  • [14]West AN, Lee RE, Shambaugh-Miller MD, Bair BD, Mueller KJ, Lilly RS, Kaboli PJ, Hawthorne K: Defining “rural” for veterans’ health care planning. J Rural Health 2010, 26(4):301-309. PMID: 21029164
  • [15]Department of Veterans Affairs Field Research Advisory Committee: Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Field Research Advisory Committee Operating Procedures. 2004. Available online: http://www.research.va.gov/resources/frac/FRAC-ops.pdf webcite. Accessed January 25, 2013
  • [16]SAS statistical software, version 9.3. Cary, NC: SAS Institute Inc;
  • [17]Nelson KM: The burden of obesity among a national probability sample of veterans. J Gen Intern Med 2006, 21(9):915-919. PMID: 16918734
  • [18]Fletcher RD, Amdur RL, Kolodner R, McManus C, Jones R, Faselis C, Kokkinos P, Singh S, Papademetriou V: Blood pressure control among US veterans: a large multiyear analysis of blood pressure data from the Veterans Administration health data repository. Circulation 2012, 125(20):2462-2468. PMID: 22515976
  • [19]Diabetes mellitus: A major risk factor for cardiovascular disease: a joint editorial statement by the American Diabetes Association; the National Heart, Lung, and Blood Institute; the Juvenile Diabetes Foundation International; the National Institute of Diabetes and Digestive and Kidney Diseases; and the American Heart Association. Circulation 1999, 100:1132-1133. PMID: 10477541
  • [20]Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B: Epidemiology of multi-morbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012, 380(9836):37-43. PMID: 22579043
  • [21]Prigerson HG, Maciejewski PK, Rosenheck RA: Population attributable fractions of psychiatric disorders and behavioral outcomes associated with combat exposure among US men. Am J Public Health 2002, 92(1):59-63. PMID: 11772762
  • [22]Marengoni A, Rizzuto D, Wang HX, Winblad B, Fratiglioni L: Patterns of chronic multi-morbidity in the elderly population. J Am Geriatr Soc 2009, 57(2):225-230. PMID: 19207138
  • [23]Smith SM, Soubhi H, Fortin M, Hudon C, O’Dowd T: Interventions for improving outcomes in patients with multi-morbidity in primary care and community settings. Cochrane Database Syst Rev 2012., 4CD006560. PMID: 22513941
  • [24]Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA: Epidemiology and impact of multi-morbidity in primary care: a retrospective cohort study. Br J Gen Pract 2011, 61(582):e12-e21. PMID: 21401985
  • [25]Glynn LG, Valderas JM, Healy P, Burke E, Newell J, Gillespie P, Murphy AW: The prevalence of multi-morbidity in primary care and its effect on health care utilization and cost. Fam Pract 2011, 28(5):516-523. PMID: 21436204
  • [26]France EF, Wyke S, Gunn JM, Mair FS, McLean G, Mercer SW: Multi-morbidity in primary care: a systematic review of prospective cohort studies. Br J Gen Pract 2012, 62(597):e297-e307. PMID: 22520918
  文献评价指标  
  下载次数:34次 浏览次数:20次